| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Twist Bioscience Corporation's insiders have reduced their positions by a net 84,591 shares worth roughly $6.7M.
TWST sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 824.0K | $95.32M | - | |
| COO | 281.8K | $32.60M | - | |
| Other | 120.1K | $13.89M | - | |
| CFO | 110.3K | $12.76M | - | |
| Other | 65.9K | $7.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2022 | Johannessen Jan71 | Director | Sell | 253 | $58.88 | $14,896.39 | -13.3% | -47.7% | -57.5% | |
| Feb 1, 2022 | Finn Patrick John71 | Chief Commercial Officer | Sale+OE | 659 | $60.52 | $39,882.68 | -1.5% | -49.7% | -53.4% | |
| Jan 25, 2022 | Banyai William81 | See Remarks | Sell | 348 | $54.73 | $19,046.04 | -0.1% | -35.7% | -47.4% | |
| Jan 21, 2022 | Banyai William81 | See Remarks | Sell | 245 | $53.36 | $13,073.20 | - | -33.0% | -48.9% | |
| Jan 18, 2022 | Leproust Emily M.75 | President &CEO | Sale+OE | 286 | $60.03 | $17,169.09 | -0.1% | -28.7% | -52.0% | |
| Jan 4, 2022 | Banyai William81 | See Remarks | Sell | 292 | $83.49 | $24,379.08 | -0.1% | -30.0% | -67.1% | |
| Dec 29, 2021 | Finn Patrick John71 | Chief Commercial Officer | Sale+OE | 5,994 | $75.62 | $453,266.28 | -11.9% | -32.3% | -68.9% | |
| Dec 27, 2021 | Leproust Emily M.75 | President &CEO | Sell | 5,300 | $80.90 | $428,779.61 | -0.7% | -41.4% | -72.7% | |
| Dec 22, 2021 | Finn Patrick John71 | Chief Commercial Officer | Sale+OE | 5,994 | $85.09 | $510,029.46 | -13.6% | -42.6% | -72.6% | |
| Dec 21, 2021 | Finn Patrick John71 | Chief Commercial Officer | Sale+OE | 219 | $82.85 | $18,144.15 | -0.6% | -45.3% | -71.9% |